相关实验视频

Updated: Mar 14, 2026

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

在产后酸模型中,突触蛋白的取决于性别和年龄的调制和行为变异性

Emre Tughan¹, Halime Dana², Ozge Nur Yilmaz³

¹Erciyes University Genome and Stem Cell Center (GENKOK) , Kayseri, Turkey; Erciyes University, Institute of Gevher Nesibe Genome and Stem Cell, Department of Molecular Biology, Kayseri, Turkey.

|March 12, 2026

概括

产后瓦尔酸 (VPA) 暴露对雄性和雌性小鼠的自闭症谱系障碍 (ASD) 模型产生不同的影响,以特定的年龄和区域的方式影响突触发育和行为.

科学领域:

神经科学是一个神经科学.
发展生物学发展生物学
自闭症谱系障碍研究研究

背景情况:

烯酸 (VPA) 暴露模型自闭症谱系障碍 (ASD) 类似的表型.
产后VPA对突触发生和突触蛋白的影响尚未完全理解.
突触干扰是ASD神经生物学的关键.

研究的目的:

在产后暴露VPA后调查年龄和性别相关的行为和突触变化.
在关键发育过程中检查VPA对后突触蛋白 (神经素,PSD-95) 的影响.
了解VPA在神经可塑性和ASD建模中的作用.

主要方法:

在出生后的第14天给C57BL/6小鼠服用一次VPA剂量.
进行的行为测试:社交互动,开放场地,嗅觉偏好,莫里斯水迷宫.
分析了海马,前额叶皮层和嗅球组织的Nrgn和PSD-95.5.

主要成果:

VPA诱导的年龄和性别依赖的行为变化,而不是统一的缺陷.
男性在运动和社会行为方面表现出更大的变化;女性在空间学习方面更有弹性.
河马NrgnmRNA和PSD-95蛋白在1个月大的男性中增加,这表明短暂的突触重塑.
分子变化是特定区域的,受年龄/性别的影响,而不仅仅是VPA治疗.

结论:

产后VPA暴露会改变突触成熟时间,性别和大脑区域的依赖性.
在VPA暴露后,海马体在青少年发育期间特别脆弱.
未来的ASD研究必须考虑神经可塑性研究的发育阶段和生物性别.

关键词:

自闭症自闭症自闭症在海马体内,海马体神经激素素是一种神经激素.嗅觉灯泡是一种嗅觉灯泡.前额叶皮层前额叶皮层.在PSD-95中,我们可以看到PSD-95.这是一个VPAVPAVPAVPAVPA.

更多相关视频

Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology

Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology

Published on: March 23, 2011

Preparation of Synaptoneurosomes from Mouse Cortex using a Discontinuous Percoll-Sucrose Density Gradient

Preparation of Synaptoneurosomes from Mouse Cortex using a Discontinuous Percoll-Sucrose Density Gradient

Published on: September 17, 2011

相关概念视频

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...